Medical Industry Feature

Tailoring Care for Medicare Patients Living with Moderate-to-Severe Plaque Psoriasis


Listen Later

Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: John Koo, MD

As the array of novel therapies for plaque psoriasis expands, a strategy to navigate treatment options is to focus on the specific needs of different patient groups, like Medicare-aged patients. ILUMYA® (tildrakizumab-asmn) is the only biologic for plaque psoriasis guaranteed to be covered under the medical benefit of Medicare, with no prior authorization and zero cost as a likely possibility. Join Dr Charles Turck and Dr John Koo as they share insights on the efficacy, safety, and accessibility of ILUMYA in this patient population. Dr. Koo is a Professor of Dermatology at the University of California at San Francisco School of Medicine.

...more
View all episodesView all episodes
Download on the App Store

Medical Industry FeatureBy ReachMD

  • 4
  • 4
  • 4
  • 4
  • 4

4

1 ratings


More shows like Medical Industry Feature

View all
SexMed by ReachMD

SexMed

3 Listeners

Partners in Practice by ReachMD

Partners in Practice

3 Listeners

Second Opinion LIVE! by ReachMD

Second Opinion LIVE!

0 Listeners

Medical Breakthroughs from Penn Medicine by ReachMD

Medical Breakthroughs from Penn Medicine

6 Listeners

Advances in Women's Health by ReachMD

Advances in Women's Health

14 Listeners

GI Insights by ReachMD

GI Insights

18 Listeners

Conference Coverage by ReachMD

Conference Coverage

0 Listeners